Stock Screener App

Frei -

2.53

1.36% -0.05

Poseida Therapeutics Inc (PSTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Poseida Therapeutics Inc Aktie (PSTX) Neueste Nachrichten

The past three years for Poseida Therapeutics (NASDAQ:PSTX) investors has not been profitable - Yahoo Movies UK

Yahoo Movies UK

It is Poised to be a Bull Market for Poseida Therapeutics Inc (PSTX) – Sete News - SETE News

These 2 'Strong Buy' Penny Stocks Could Rally to $10 (or More), Say Analysts - Markets Insider

Markets Insider

The past three years for Poseida Therapeutics (NASDAQ:PSTX) investors has not been profitable - Yahoo Movies UK

Yahoo Movies UK

PSTX Stock Update: Poseida Therapeutics Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

The InvestChronicle

Cantor Fitzgerald L. P. Purchases New Stake in Poseida Therapeutics, Inc. (NASDAQ:PSTX) - Defense World

Reviewing Poseida Therapeutics (NASDAQ:PSTX) and Biogen (NASDAQ:BIIB) - Defense World

Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders - Lelezard

Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders - The Malaysian Reserve

The Malaysian Reserve

Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders - Marketscreener.com

Marketscreener.com

Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders - Yahoo Finance

Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders - Yahoo Finance

Poseida Therapeutics, Inc. (NASDAQ:PSTX) Short Interest Update - MarketBeat

Poseida Therapeutics, Inc. (NASDAQ:PSTX) Short Interest Update - Defense World

Poseida Therapeutics, Inc. (NASDAQ:PSTX) Short Interest Update - MarketBeat

Quarterly Snapshot: Quick and Current Ratios for Poseida Therapeutics Inc (PSTX) – DWinneX - The Dwinnex

Poseida Therapeutics Partners With Astellas: Worth Watching For Now (NASDAQ:PSTX) - Seeking Alpha

10459 Shares in Poseida Therapeutics, Inc. (NASDAQ:PSTX) Acquired by Dynamic Technology Lab Private Ltd - Defense World

Poseida Therapeutics Partners With Astellas: Worth Watching For Now (NASDAQ:PSTX) - Seeking Alpha

What is Poseida Therapeutics Inc (PSTX) Stock Return on Shareholders' Capital? – Sete News - SETE News

Poseida Therapeutics, Inc. to Post Q2 2024 Earnings of ($0.43) Per Share, HC Wainwright Forecasts (NASDAQ:PSTX) - Defense World

Poseida Therapeutics, Inc. to Post Q2 2024 Earnings of ($0.43) Per Share, HC Wainwright Forecasts (NASDAQ:PSTX) - Defense World

Poseida Therapeutics, Inc. Forecasted to Post Q2 2024 Earnings of ($0.43) Per Share (NASDAQ:PSTX) - MarketBeat

Poseida Therapeutics, Inc. (NASDAQ:PSTX) Expected to Post Q3 2025 Earnings of ($0.49) Per Share - Defense World

Poseida Therapeutics, Inc. (NASDAQ:PSTX) Expected to Post Q3 2025 Earnings of ($0.49) Per Share - Defense World

Q3 2025 Earnings Estimate for Poseida Therapeutics, Inc. (NASDAQ:PSTX) Issued By HC Wainwright - MarketBeat

Poseida Therapeutics (NASDAQ:PSTX) Receives Buy Rating from HC Wainwright - Defense World

Q3 2025 Earnings Estimate for Poseida Therapeutics, Inc. (NASDAQ:PSTX) Issued By HC Wainwright - MarketBeat

Poseida Therapeutics (NASDAQ:PSTX) Earns Buy Rating from HC Wainwright - MarketBeat

Company’s Banking Stock: Dissecting a -11.08% Quarterly Revenue Decline Amid Growth - The InvestChronicle

The InvestChronicle

Financial Metrics Unveiled: Poseida Therapeutics Inc (PSTX)'s Key Ratios in the Spotlight – DWinneX - The Dwinnex

Ready to Jump After Recent Trade: Poseida Therapeutics Inc (PSTX) – Sete News - SETE News

Biotech Soars on Research Collaboration And License Agreement Release - The Globe and Mail

The Globe and Mail

Do investors need to be concerned about Poseida Therapeutics Inc (PSTX)? – US Post News - US Post News

Poseida Therapeutics (NASDAQ:PSTX) Has Debt But No Earnings; Should You Worry? - Simply Wall St

Poseida Therapeutics (NASDAQ:PSTX) Has Debt But No Earnings; Should You Worry? - Simply Wall St

New York State Common Retirement Fund Sells 17966 Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX) - Defense World

New York State Common Retirement Fund Sells 17966 Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX) - Defense World

Biotech Soars on Research Collaboration And License Agreement Release - The Globe and Mail

The Globe and Mail

William Blair Weighs in on Poseida Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:PSTX) - Defense World

Q2 2024 EPS Estimates for Poseida Therapeutics, Inc. (NASDAQ:PSTX) Cut by Analyst - MarketBeat

Poseida Therapeutics Inc (PSTX) Stock: Uncovering 52-Week Market Trends - The InvestChronicle

The InvestChronicle

Poseida Therapeutics Inc (PSTX) Stock: Uncovering 52-Week Market Trends - The InvestChronicle

The InvestChronicle

PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q1 2024 - MSN

Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024 - PR Newswire

Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024 - PR Newswire

Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates

Zacks Investment Research

Institutional investors may adopt severe steps after Poseida Therapeutics, Inc.'s (NASDAQ:PSTX) latest 13% drop adds ... - Yahoo Lifestyle UK

Yahoo Lifestyle UK

One to Watch Companies - USA, SY-2101, Poseida Therapeutics - The Pharma Letter

The Pharma Letter

Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell ... - PR Newswire

$146.84

2.64%

$84.77

0.25%

$25.70

0.23%

$84.20

2.90%

$447.85

0.91%

$247.55

3.18%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen